Subsequently, BCL-2 silencing in neuroblastoma cells was shown to induce apoptotic cell death [77] while ABT-199 also synergised with fenretinide in both neuroblastoma cell lines and PDX models expressing high BCL-2 levels, where improved event-free survival was demonstrated [91]. This evidence concerns the gene BCL2 and neuroblastoma.